unige:143063 | Application of modeling approaches to explore vaccine adjuvant mode-of-action | Buckley, Paul R; Alden, Kieran; Coccia, Margherita; Chalon, Aurélie; ... Coles, Mark C |
unige:143061 | Clarification regarding the statement of the association between the recombinant zoster vaccine (RZV) and gout flares | Didierlaurent, Arnaud; Desssart, Christophe; Cunningham, Anthony L; |
unige:143068 | Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans | Burny, Wivine; Marchant, Arnaud; Hervé, Caroline; Callegaro, Andrea; ... Yarzabal, Juan |
unige:143067 | Peripheral lymph nodes contain migratory and resident innate lymphoid cell populations | Dutton, Emma E; Gajdasik, Dominika W; Willis, Claire; Fiancette, Remi; ... Withers, David R |
unige:143062 | The how's and what's of vaccine reactogenicity | Hervé, Caroline; Laupèze, Béatrice; Del Giudice, Giuseppe; Didierlaurent, Arnaud; Tavares Da Silva, Fernanda |
unige:143064 | Toll‐like receptor 4 signaling in hematopoietic‐lineage cells contributes to the enhanced activity of the human vaccine adjuvant AS01 | Van Maele, Laurye; Fougeron, Delphine; Cayet, Delphine; Chalon, Aurélie; ... Didierlaurent, Arnaud |